Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry to Demonstrate the Clinical Utility of CELLSEARCH® Circulating Tumor Cell (CTC) Test in Medicare-Eligible Metastatic Breast Cancer Patients

NCT02111031 is registered in ClinicalTrials.gov with Janssen Diagnostics, LLC as lead sponsor.

NCT NCT02111031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry to Demonstrate the Clinical Utility of CELLSEARCH® Circulating Tumor Cell (CTC) Test in Medicare-Eligible Metastatic Breast Cancer Patients
Lead sponsor
Janssen Diagnostics, LLC
Phase
Observational
Overall status
Withdrawn
Start date
January 31, 2016
Completion date
May 31, 2017
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic breast cancer